Nathan Rich
Stock Analyst at Goldman Sachs
(1.18)
# 3,767
Out of 5,148 analysts
85
Total ratings
36.51%
Success rate
-9.94%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $187.28 | -15.63% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $13.98 | +50.21% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $128.96 | +51.99% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $14.31 | +109.64% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $13.77 | -41.90% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $29.44 | -40.56% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $26.09 | -46.34% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $33.77 | -67.43% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $189.02 | +19.04% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $636.70 | +2.09% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $81.66 | +7.76% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $19.65 | -38.93% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $81.37 | +4.46% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $15.70 | -29.94% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $152.42 | +119.79% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $294.93 | +81.40% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $187.28
Upside: -15.63%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $13.98
Upside: +50.21%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $128.96
Upside: +51.99%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $14.31
Upside: +109.64%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $13.77
Upside: -41.90%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $29.44
Upside: -40.56%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $26.09
Upside: -46.34%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $33.77
Upside: -67.43%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $189.02
Upside: +19.04%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $636.70
Upside: +2.09%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $81.66
Upside: +7.76%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $19.65
Upside: -38.93%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $81.37
Upside: +4.46%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $15.70
Upside: -29.94%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $152.42
Upside: +119.79%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $294.93
Upside: +81.40%